Alerts will be sent to your verified email
Verify Email
SAROJA
|
Saroja Pharma Ind
|
Starsource Multitrad
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
27.98 % | -4.44 % | 10.99 % |
|
5yr average Equity Multiplier
|
4.23 | 1.01 | 1.23 |
|
5yr Average Asset Turnover Ratio
|
2.66 | 0.0 | 0.25 |
|
5yr Avg Net Profit Margin
|
2.05 % | 0.0 | 77.44 % |
|
Price to Book
|
1.02 | 11.82 | 1.88 |
|
P/E
|
15.32 | 0.0 | 63.5 |
|
5yr Avg Cash Conversion Cycle
|
72.5 Days | 0.0 | 63.13 Days |
|
Inventory Days
|
9.36 Days | 0.0 | 54.75 Days |
|
Days Receivable
|
145.45 Days | 0.0 | 11.98 Days |
|
Days Payable
|
53.02 Days | 0.0 | 169.78 Days |
|
5yr Average Interest Coverage Ratio
|
2.62 | 670.55 | 820.35 |
|
5yr Avg ROCE
|
33.47 % | -2.98 % | 17.27 % |
|
5yr Avg Operating Profit Margin
|
4.85 % | 0.0 | -130.11 % |
|
5 yr average Debt to Equity
|
1.55 | 0.01 | 0.0 |
|
5yr CAGR Net Profit
|
7.13 % | n/a | -26.08 % |
|
5yr Average Return on Assets
|
5.43 % | -4.07 % | 8.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
73.02 % | 27.89 % | 59.53 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 3.22 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Saroja Pharma Ind
|
Starsource Multitrad
|
Emmessar Biotech&Nut
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|